Lipid Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Out of Business
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Out of Business

Lipid Therapeutics General Information

Description

Provider of therapies intended to cure inflammatory diseases of the digestive system. The company's therapies work on the clinical development of LT-02, a sustained release formulation of phosphatidylcholine for the treatment of ulcerative colitis, enabling patients to get treatment of various digestive system.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
  • Boxbergring 107
  • 69126 Heidelberg
  • Germany
+49 06221 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipid Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2019 Completed Out of Business
1. Early Stage VC 01-Jan-2008 Completed Startup
To view Lipid Therapeutics’s complete valuation and funding history, request access »

Lipid Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial